Indianapolis
Eli Lilly will begin construction in late 2012 on a $140 million expansion of its Indianapolis pharmaceutical manufacturing campus. The 80,000-sf addition will support the production of insulin cartridges. Completion is expected in March of 2014 with operations beginning in 2015.
Source
